• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无虹膜性青光眼:长期视觉预后及表型关联

Aniridic Glaucoma: Long-term Visual Outcomes and Phenotypic Associations.

作者信息

Jain Amit, Gupta Shikha, James Mathew K, Dutta Paromita, Gupta Viney

机构信息

Department of Ophthalmology, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

出版信息

J Glaucoma. 2015 Sep;24(7):539-42. doi: 10.1097/IJG.0000000000000019.

DOI:10.1097/IJG.0000000000000019
PMID:24618569
Abstract

PURPOSE

The aim of this study was to evaluate long-term visual outcomes in patients with aniridic glaucoma.

DESIGN

Retrospective noncomparative observational case series.

MATERIALS AND METHODS

A review of medical records of 128 eyes of 64 consecutive patients with aniridic glaucoma, diagnosed after the age of 5 years was analyzed. The parameters studied included age at presentation, family history, baseline intraocular pressure (IOP), type and the number of surgical interventions, and associated comorbidities.

PRIMARY OUTCOME MEASURE

Best corrected visual acuity (BCVA) in the better eye.

RESULTS

Mean age at presentation was 15.86±10.11 years (range, 5 to 47 y). The average follow-up was 7.69±4.98 years (range, 1 to 17 y). At the final follow up only 18 patients had BCVA better than 6\60 and only 5 patients had BCVA of >6/18. Seventeen of the 64 (26.5%) patients developed phthisis in 1 eye. The final visual outcomes were not associated with age at presentation (P=0.64) or sex (P=0.76); however, those with a higher baseline IOP (P=0.017), those with familial aniridia (P=0.037), and those who underwent more number of surgical interventions had poorer visual outcomes (P=0.004). Kaplan-Meier analysis demonstrated the probability of bilateral blindness to be 69.8% and 97.6% at 5 and 10 years, respectively.

CONCLUSIONS

Long-term visual outcomes after therapy among aniridic glaucoma patients remain poor. Higher baseline IOP, the presence of familial aniridia, and a history of greater number of surgical interventions are associated with poorer long-term visual outcomes.

摘要

目的

本研究旨在评估无虹膜性青光眼患者的长期视觉预后。

设计

回顾性非对照观察性病例系列。

材料与方法

对64例连续的无虹膜性青光眼患者的128只眼的病历进行分析,这些患者在5岁以后被诊断出来。研究的参数包括就诊时的年龄、家族史、基线眼压(IOP)、手术干预的类型和次数以及相关的合并症。

主要观察指标

较好眼的最佳矫正视力(BCVA)。

结果

就诊时的平均年龄为15.86±10.11岁(范围为5至47岁)。平均随访时间为7.69±4.98年(范围为1至17年)。在最后一次随访时,只有18例患者的BCVA优于6/60,只有5例患者的BCVA>6/18。64例患者中有17例(26.5%)一只眼发生眼球痨。最终的视觉预后与就诊时的年龄(P=0.64)或性别(P=0.76)无关;然而,基线眼压较高者(P=0.017)、患有家族性无虹膜者(P=0.037)以及接受手术干预次数较多者的视觉预后较差(P=0.004)。Kaplan-Meier分析表明,5年和10年时双眼失明的概率分别为69.8%和97.6%。

结论

无虹膜性青光眼患者治疗后的长期视觉预后仍然很差。较高的基线眼压、家族性无虹膜的存在以及手术干预次数较多与较差的长期视觉预后相关。

相似文献

1
Aniridic Glaucoma: Long-term Visual Outcomes and Phenotypic Associations.无虹膜性青光眼:长期视觉预后及表型关联
J Glaucoma. 2015 Sep;24(7):539-42. doi: 10.1097/IJG.0000000000000019.
2
Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas.艾哈迈德青光眼引流阀植入术治疗难治性青光眼的长期疗效
Am J Ophthalmol. 2007 Dec;144(6):893-900. doi: 10.1016/j.ajo.2007.07.035. Epub 2007 Oct 4.
3
Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.婴儿期内施行的丝裂霉素 C 增强小梁切除术的长期疗效。
Ophthalmology. 2015 Nov;122(11):2216-22. doi: 10.1016/j.ophtha.2015.07.028. Epub 2015 Aug 24.
4
Surgical outcomes in childhood uveitic glaucoma.儿童葡萄膜炎性青光眼的手术治疗效果。
Am J Ophthalmol. 2013 Jan;155(1):134-42. doi: 10.1016/j.ajo.2012.07.008. Epub 2012 Oct 2.
5
Intraocular pressure control after the implantation of a second Ahmed glaucoma valve.植入第二个艾哈迈德青光眼引流阀后的眼压控制
Int Ophthalmol. 2016 Jun;36(3):347-53. doi: 10.1007/s10792-015-0125-z. Epub 2015 Sep 3.
6
Short- and Long-term Results of Glaucoma Valve Implantation for Aniridia-related Glaucoma: A Case Series and Literature Review.无虹膜相关性青光眼的青光眼引流阀植入术的短期和长期结果:病例系列及文献综述
Turk J Ophthalmol. 2019 Sep 3;49(4):183-187. doi: 10.4274/tjo.galenos.2019.07348.
7
Outcome of surgery on infants younger than 1 month with congenital glaucoma.1个月以下先天性青光眼婴儿的手术结果
Ophthalmology. 2003 Oct;110(10):1909-15. doi: 10.1016/S0161-6420(03)00671-7.
8
Prevalence, Incidence, and Risk Factors for the Development of Glaucoma in Patients With Aniridia.无虹膜患者青光眼的患病率、发病率及发病危险因素
J Pediatr Ophthalmol Strabismus. 2017 Jul 1;54(4):250-255. doi: 10.3928/01913913-20170322-01. Epub 2017 May 17.
9
Goniosurgery for prevention of aniridic glaucoma.用于预防无虹膜性青光眼的前房角手术。
Trans Am Ophthalmol Soc. 1998;96:155-65; discussion 165-9.
10
Trabeculectomy or Transscleral Cyclophotocoagulation as Initial Treatment of Secondary Childhood Glaucoma in Northern Tanzania.小梁切除术或经巩膜睫状体光凝术作为坦桑尼亚北部儿童继发性青光眼的初始治疗方法
J Glaucoma. 2017 Jul;26(7):657-660. doi: 10.1097/IJG.0000000000000682.

引用本文的文献

1
Increased sensitivity of primary aniridia limbal stromal cells to travoprost, leading to elevated migration and MMP-9 protein levels, in vitro.体外实验中,原发性无虹膜角膜缘基质细胞对曲伏前列素的敏感性增加,导致其迁移和基质金属蛋白酶-9(MMP-9)蛋白水平升高。
PLoS One. 2025 Jun 26;20(6):e0326967. doi: 10.1371/journal.pone.0326967. eCollection 2025.
2
Comprehensive Analysis of Congenital Aniridia and Differential Diagnoses: Genetic Insights and Clinical Manifestations.先天性无虹膜综合分析及鉴别诊断:遗传学见解与临床表现
Ophthalmol Ther. 2025 May;14(5):835-856. doi: 10.1007/s40123-025-01122-1. Epub 2025 Mar 26.
3
A rare missense mutation causes atypical aniridia in a three-generation Chinese family.
一个罕见的错义突变导致一个三代中国家庭出现非典型无虹膜症。
Int J Ophthalmol. 2024 Mar 18;17(3):466-472. doi: 10.18240/ijo.2024.03.07. eCollection 2024.
4
Clinical and molecular aspects of congenital aniridia - A review of current concepts.先天性无虹膜的临床和分子方面——当前概念综述。
Indian J Ophthalmol. 2022 Jul;70(7):2280-2292. doi: 10.4103/ijo.IJO_2255_21.
5
Clinical outcomes and visual prognostic factors in congenital aniridia.先天性无虹膜的临床结果和视觉预后因素。
BMC Ophthalmol. 2022 May 25;22(1):235. doi: 10.1186/s12886-022-02460-5.
6
Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma.改善无虹膜性青光眼患者的长期眼压和视力预后。
Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3749-3755. doi: 10.1007/s00417-021-05335-5. Epub 2021 Jul 30.
7
Congenital aniridia: clinical profile of children seen at the University College Hospital, Ibadan, South-West Nigeria.先天性无虹膜:尼日利亚西南部伊巴丹大学学院医院儿童的临床概况
Ther Adv Ophthalmol. 2021 May 31;13:25158414211019513. doi: 10.1177/25158414211019513. eCollection 2021 Jan-Dec.
8
Use of the XEN gel implant in a patient with aniridia-associated glaucoma.XEN凝胶植入物在无虹膜相关性青光眼患者中的应用。
Am J Ophthalmol Case Rep. 2021 Mar 31;22:101080. doi: 10.1016/j.ajoc.2021.101080. eCollection 2021 Jun.
9
Short- and Long-term Results of Glaucoma Valve Implantation for Aniridia-related Glaucoma: A Case Series and Literature Review.无虹膜相关性青光眼的青光眼引流阀植入术的短期和长期结果:病例系列及文献综述
Turk J Ophthalmol. 2019 Sep 3;49(4):183-187. doi: 10.4274/tjo.galenos.2019.07348.
10
Congenital aniridia: etiology, manifestations and management.先天性无虹膜:病因、临床表现及治疗
Expert Rev Ophthalmol. 2016;11(2):135-144. doi: 10.1586/17469899.2016.1152182. Epub 2016 Mar 9.